Elemento

EPICC Research Study

Título (Dublin Core)

EPICC Research Study

Description (Dublin Core)

In October 2021 I was selected to voluntarily participate in the EPICC DoD Research Study on COVID-19. This study is focused on adulty active duty and non-active duty military service members who have tested for, had, or is vaccinated against COVID-19, and part of the Military Health System. I had never participated in a study before and honestly what hooked me was the $10 Amazon gift card they would give us for participating.
Fast forward six months and I have completed three questionaries and one at-home blood sample kit. I think it's pretty cool to be participating in something that may improve the Military Health System overall and also provide data points for future research of COVID-19. Studies like this show how novel this virus really was and how we want to learn as much as we can about it in an effort to be more prepared for similar events in the future.

Date (Dublin Core)

March 27, 2022

Creator (Dublin Core)

self

Contributor (Dublin Core)

Bryan Paintiff

Event Identifier (Dublin Core)

HST580

Partner (Dublin Core)

Arizona State University

Tipo (Dublin Core)

text story

Link (Bibliographic Ontology)

Controlled Vocabulary (Dublin Core)

English Healthcare
English Public Health & Hospitals
English Government Federal

Curator's Tags (Omeka Classic)

research
vaccine
military
test
at-home

Contributor's Tags (a true folksonomy) (Friend of a Friend)

Military
research study
DoD
Active Duty
EPICC

Collection (Dublin Core)

Healthcare

Linked Data (Dublin Core)

Date Submitted (Dublin Core)

03/27/2022

Date Modified (Dublin Core)

03/28/2022
05/29/2022
08/02/2022

Colecciones

This item was submitted on March 27, 2022 by Bryan Paintiff using the form “Share Your Story” on the site “A Journal of the Plague Year”: http://mail.covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA